Insmed (INSM) Shares Outstanding (2010 - 2026)

Insmed has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $218.3 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 3.4% year-over-year to $218.3 million in Q2 2026; TTM through Jun 2026 was $218.3 million, a 3.4% increase from a year earlier, with the FY2025 full-year figure at $214.3 million, up 19.44% from the prior year.
• Shares Outstanding (Entity) was $218.3 million for Q2 2026 at Insmed, up from $216.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $218.3 million in Q2 2026, with the low at $119.3 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $166.4 million, with a median of $157.6 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) grew 2.85% in 2022, then increased 26.67% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $135.7 million in 2022, then advanced by 9.09% to $148.0 million in 2023, then rose by 21.22% to $179.4 million in 2024, then grew by 19.44% to $214.3 million in 2025, then gained by 1.88% to $218.3 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $218.3 million (Q2 2026), $216.5 million (Q1 2026), and $214.3 million (Q4 2025), per Business Quant data.